IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners LLC

Q3 2019 Holdings

Filed 2019-11-14 | 6 holdings | $210.8K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2020-05-20) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Akero Therapeutics Inc(AKRO)COM00973Y108$90.0K3,954,85842.7%
Turning Point Therapeutics ICOM90041T108$50.4K1,340,26523.9%
Precision Biosciences IncCOM74019P108$35.8K4,265,14117.0%
Apellis Pharmaceuticals Inc(APLS)ACOM03753U106$24.1K1,000,00011.4%
Apellis Pharmaceuticals, IncCOM037530106$24.1K1,000,00011.4%
Menlo Therapeutics IncCOM586858102$6.5K1,461,5523.1%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$4.0K875,0001.9%